US restricts, EU bans controversial diabetes pill
European health regulators have banned sales of the once-blockbuster diabetes drug Avandia because of evidence it raises the risk of heart attack, but doctors in the US will be able to continue prescribing it with some significant restrictions.
In simultaneous news briefings, the European Medicines Agency and the US Food and Drug Administration announced their decisions on the controversial drug. The European regulator said it would stop authorizing marketing of Avandia and said it would be removed from the market within the next few months. (AP)
